Page last updated: 2024-10-25

deferoxamine and Leukemia L5178

deferoxamine has been researched along with Leukemia L5178 in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Leukemia L5178: An experimental lymphocytic leukemia of mice.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kruszewski, M2
Green, MH1
Lowe, JE1
Szumiel, I2
Iwaneńko, T1
Bouzyk, E1

Other Studies

2 other studies available for deferoxamine and Leukemia L5178

ArticleYear
Comparison of effects of iron and calcium chelators on the response of L5178Y sublines to X-rays and H2O2.
    Mutation research, 1995, Volume: 326, Issue:2

    Topics: Aminoquinolines; Animals; Antimutagenic Agents; Calcium; Cell Survival; Chelating Agents; Deferoxami

1995
Chelating of iron and copper alters properties of DNA in L5178Y cells, as revealed by the comet assay.
    Mutation research, 1999, May-14, Volume: 434, Issue:1

    Topics: Animals; Cell Count; Cell Nucleus; Cell Survival; Chelating Agents; Copper; Deferoxamine; DNA Damage

1999